ArticleCardiology and therapy2020

Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry.

Uwe Zeymer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.